0001698865-23-000001.txt : 20230208
0001698865-23-000001.hdr.sgml : 20230208
20230208145618
ACCESSION NUMBER: 0001698865-23-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230208
DATE AS OF CHANGE: 20230208
EFFECTIVENESS DATE: 20230208
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Accure Acne, Inc.
CENTRAL INDEX KEY: 0001698865
IRS NUMBER: 814819638
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-472975
FILM NUMBER: 23598730
BUSINESS ADDRESS:
STREET 1: 384 INVERNESS PARKWAY, #125
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
BUSINESS PHONE: 303-886-6125
MAIL ADDRESS:
STREET 1: 384 INVERNESS PARKWAY, #125
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
D
1
primary_doc.xml
X0708
D
LIVE
0001698865
Accure Acne, Inc.
4699 Nautilus Court South
Suite 250
Boulder
CO
COLORADO
80301
9706882498
DELAWARE
None
None
Corporation
true
Karl
Nicholls
4699 Nautilus Court South
Suite 250
Boulder
CO
COLORADO
80301
Executive Officer
Christopher
Carlton
4699 Nautilus Court South
Suite 250
Boulder
CO
COLORADO
80301
Executive Officer
Director
Edward
Barbera
4699 Nautilus Court South
Suite 250
Boulder
CO
COLORADO
80301
Director
Samuel
E
Navarro
4699 Nautilus Court South
Suite 250
Boulder
CO
COLORADO
80301
Director
Jeffrey
O'Donnell
4699 Nautilus Court South
Suite 250
Boulder
CO
COLORADO
80301
Director
Other Health Care
Decline to Disclose
- 06b
false
2023-01-26
false
true
true
true
true
false
25000
Maxim Group LLC
120708
None
None
300 Park Ave
16th Floor
New York
NY
NEW YORK
10022
All States
false
20000000
7951197
12048803
false
20
362500
true
0
10% of total cash consideration received by the Company. Also issuance of warrants to purchase equity equal to 10% of total securities being sold or issued.
0
true
false
Accure Acne, Inc.
/s/ Karl Nicholls
Karl Nicholls
Chief Financial Officer
2023-02-08